Variant report
Variant | esv3335635 |
---|---|
Chromosome Location | chr6:26864873-26872771 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HIST1H2AG-6 | chr6:26865674-26866556 | NONHSAT108314 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540903776 | chr6:26864905-26864906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564375640 | chr6:26864908-26864909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201721490 | chr6:26864938-26864939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563340916 | chr6:26864962-26864963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9286717 | chr6:26864989-26864990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527697858 | chr6:26865010-26865011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199673883 | chr6:26865015-26865016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9717366 | chr6:26865032-26865033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565665142 | chr6:26865045-26865046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528123969 | chr6:26865066-26865067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9467927 | chr6:26865081-26865082 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs571878475 | chr6:26865083-26865084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537355899 | chr6:26865113-26865114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184219694 | chr6:26865166-26865167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567800358 | chr6:26865176-26865177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150509070 | chr6:26865182-26865183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138329826 | chr6:26865197-26865198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372041870 | chr6:26865198-26865199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538612041 | chr6:26865199-26865200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9295713 | chr6:26865215-26865216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180981111 | chr6:26865256-26865257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9688956 | chr6:26865268-26865269 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
23 | rs9688544 | chr6:26865269-26865270 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
24 | rs532811468 | chr6:26865327-26865328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562427029 | chr6:26865338-26865339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200747044 | chr6:26865346-26865347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547778550 | chr6:26865380-26865381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201367765 | chr6:26865384-26865385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573917335 | chr6:26865390-26865391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542723077 | chr6:26865394-26865395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559464603 | chr6:26865397-26865398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528213889 | chr6:26865418-26865419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551319140 | chr6:26865434-26865435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564772468 | chr6:26865458-26865459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531223312 | chr6:26865492-26865493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12181587 | chr6:26865500-26865501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs62400838 | chr6:26865550-26865551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567824096 | chr6:26865575-26865576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71557358 | chr6:26865600-26865601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546804668 | chr6:26865604-26865605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566585587 | chr6:26865649-26865650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12178306 | chr6:26865669-26865670 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs140115952 | chr6:26865703-26865704 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs12180063 | chr6:26865728-26865729 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs575590451 | chr6:26865734-26865735 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs374808080 | chr6:26865738-26865739 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs537337054 | chr6:26865740-26865741 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs369169186 | chr6:26865745-26865746 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs190565582 | chr6:26865753-26865754 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs574008128 | chr6:26865754-26865755 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26838000-26866200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr6:26841400-26866200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr6:26844400-26865800 | Weak transcription | Ovary | ovary |
4 | chr6:26844400-26872000 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr6:26849200-26866800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
6 | chr6:26849400-26866600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr6:26850400-26865000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr6:26852000-26866200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr6:26861400-26865800 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr6:26862200-26866600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:26864400-26866600 | Weak transcription | Fetal Muscle Trunk | muscle |
12 | chr6:26865800-26867600 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr6:26866400-26867000 | Enhancers | Fetal Muscle Leg | muscle |
14 | chr6:26866600-26866800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr6:26866600-26867200 | Enhancers | Fetal Muscle Trunk | muscle |
16 | chr6:26866600-26867400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr6:26866800-26867000 | Enhancers | Skeletal Muscle Male | skeletal muscle |